Analyst Ratings January 27, 2026

Oppenheimer Lowers AMETEK Rating to Perform Citing Rich Valuation Despite Operational Strength

Analyst trims outlook on AMETEK (AME) as multiples outpace perceived fair value even as order trends and margin catalysts show promise

By Hana Yamamoto AME
Oppenheimer Lowers AMETEK Rating to Perform Citing Rich Valuation Despite Operational Strength
AME

Oppenheimer has reduced its rating on AMETEK Inc. (NYSE: AME) from Outperform to Perform, pointing to valuation pressures even as the company posts solid order momentum and improving operational indicators. Key financial metrics and recent quarterly results underscore a mix of durable fundamentals and stretched multiples that informed the analyst action.

Key Points

  • Oppenheimer downgraded AMETEK from Outperform to Perform predominantly due to valuation concerns; P/E is 34.65 and PEG is 3.31, with data indicating the stock trades above its assessed Fair Value.
  • Operational indicators remain healthy: company-wide book-to-bill was 1.04x in Q3 2025, EMG matched 1.04x with 12% organic growth, and overall revenue for the last twelve months was $7.16 billion (3.67% growth).
  • Financial stability and shareholder returns are intact: net leverage 0.9x, Total Debt to Total Capital 0.05, Altman Z-Score 11.8, and 55 consecutive years of dividend payments (current yield 0.56%).

Oppenheimer downgraded AMETEK Inc. (NYSE: AME) from Outperform to Perform on Tuesday, citing valuation as the principal concern despite a number of encouraging operational datapoints. The firm highlighted the stock's current price-to-earnings ratio of 34.65 and a PEG ratio of 3.31 as evidence that the shares are trading above an assessed Fair Value, supporting a more conservative near-term rating.

Operationally, AMETEK demonstrated continued order strength in the third quarter of 2025, reporting a company-wide book-to-bill ratio of 1.04x. The Electronic Manufacturing Group (EMG) mirrored that 1.04x book-to-bill result while delivering 12% organic growth, an outcome noted by the analyst as a driver of positive revenue momentum.

Overall, AMETEK generated $7.16 billion in revenue for the last twelve months, representing a 3.67% year-over-year revenue growth rate. Within the Electronic Instruments Group (EIG), management reported a 1.02x book-to-bill ratio alongside flat organic growth, although Oppenheimer observed nascent signs of a positive pivot in longer cycle markets. The report indicated that process market dynamics inside EIG showed steady sequential improvement, with robust customer engagement and an expanding pipeline.

The research note called out Power & Industrial as a segment generating incremental engagement in resilient end markets for power quality and conditioning, with particular strength in utility and datacenter customers. Oppenheimer also suggested that EMG could deliver margin upside in 2026, following substantial cost-structure actions and integration work already undertaken.

Despite the rating reduction, the analyst acknowledged several risk-mitigating factors in AMETEK's profile. These include high-quality operations, disciplined portfolio management and a flexible balance sheet, with net leverage reported at 0.9x. Supporting metrics cited in the analysis show a very low Total Debt to Total Capital ratio of 0.05 and an Altman Z-Score of 11.8, both of which point to low financial-stress risk. The company has sustained dividend payments for 55 consecutive years, currently yielding 0.56%.

Recent quarterly results reinforce the operational narrative. In the third quarter of 2025 AMETEK reported earnings per share of $1.89, above consensus expectations of $1.76, while revenue reached a record $1.89 billion versus an expected $1.81 billion. On the corporate-governance front, the company announced executive appointments effective January 1, 2026: Robert J. Amodei will become Senior Vice President, Controller following the retirement of Thomas M. Montgomery, and Scott M. DelOrefice will assume the role of Vice President, Group Controller, Electromechanical Group.

Shareholder returns remain active. The board declared a regular quarterly dividend of $0.31 per share payable on December 19, 2025, to shareholders of record as of December 5, 2025. On the product side, AMETEK's SkyBitz division introduced the SmartTank ST705 Radar Monitor, a new sensor aimed at industrial fluid tracking.

Independent data referenced in the analyst commentary and company disclosures underpin the view that, while AMETEK's underlying business trends and balance-sheet health are constructive, elevated market multiples are the key reason for Oppenheimer's move to a more neutral rating. The firm also noted that other analysts remain active on the name; for example, DA Davidson has increased its price target for AMETEK to $240, citing optimism on organic growth and margin prospects.


Contextual takeaways

  • Valuation is the proximate driver of the downgrade, with the share price trading at elevated P/E and PEG multiples relative to the analyst's fair-value assessment.
  • Order flow and segment-level dynamics provide operational support, with EMG showing particular strength and Power & Industrial engaging resilient markets.
  • Balance-sheet metrics and a long dividend track record reduce downside risk from a credit and income perspective.

Risks

  • Valuation risk - the stock's elevated P/E and PEG ratios underpin the downgrade and imply sensitivity to multiple contraction, affecting equity investors in the industrials and electronic components sectors.
  • Execution risk in longer-cycle end markets - EIG exhibited flat organic growth and depends on a positive pivot in longer cycle markets to reaccelerate growth, which could affect segment revenues and margins.
  • Integration and margin realization risk - EMG has undertaken significant cost-structure and integration work; failure to realize anticipated margin upside in 2026 would pressure profitability in manufacturing and electromechanical end markets.

More from Analyst Ratings

Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026 Needham Lifts Napco Security Price Target to $49 After Robust Q2 Results Feb 2, 2026 Evercore ISI Sticks with Outperform on Apple, Sets $330 Target Backed by App Store and Services Strength Feb 2, 2026 Deutsche Bank Says AppLovin Risk-Reward Looks Better After Google’s Project Genie Shock Feb 2, 2026